Halozyme Therapeutics Inc (HALO) Stock: A Comprehensive 52-Week Review

ZM Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Halozyme Therapeutics Inc’s current trading price is 3.44% away from its 52-week high, while its distance from the 52-week low is 67.04%. The stock’s price range over this period has fluctuated between $40.87 and $66.00. The company, operating within the financial sector, had a trading volume of approximately 3.74 million for the day, which was noticeably higher than the average daily share volume of 1.48 million over the last 3 months.

In terms of market performance, Halozyme Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $66.00 on 05/07/25, and the lowest value was recorded at $40.87 on 05/09/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Halozyme Therapeutics Inc (HALO) has experienced a quarterly rise of 18.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.43B and boasts a workforce of 350 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 57.20, with a change in price of +17.92. Similarly, Halozyme Therapeutics Inc recorded 1,462,163 in trading volume during the last 100 days, posting a change of +36.54%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for HALO stands at 4.22. Similarly, the long-term debt-to-equity ratio is also 4.20.

HALO Stock Stochastic Average

Today’s raw stochastic average for Halozyme Therapeutics Inc over the last 50 days is 84.39%.This indicates a increase from the raw stochastic average of the past 20 days, which was 84.39%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 72.61% and 72.91%, respectively.

HALO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 42.79%. However, over the past six months, we’ve seen a weaker performance of 19.46%. The price of HALO fallen by 15.03% over the last 30 days. And in the last five days, it has surged by 11.15%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.